Author

R. M. Zhang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Gordon· 2 shared D. D. Ho· 2 shared J. Ho· 2 shared L. Liu· 2 shared Q. Wang· 2 shared R. Valdez· 2 shared Y. Guo· 2 shared A. Collins· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Gordon

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

Q. Wang, Y. Guo, L. Liu, L. T. Schwanz, Z. Li, J. Ho, R. M. Zhang, S. Iketani, J. Yu, Y. Huang, Y. Qu, R. Valdez, A. S. Lauring, A. Gordon, H. H. Wang, , D. D. Ho

This paper evaluates the antigenicity and receptor affinity of the SARS-CoV-2 BA.2.86 subvariant, finding it not more resistant to human sera than other variants but with specific mAb resistance and high receptor affinity.

bioRxiv · Sep 24, 2023Microbiology

Antibody Neutralization of Emerging SARS-CoV-2: EG.5.1 and XBC.1.6

Q. Wang, Y. Guo, R. M. Zhang, J. Ho, H. Mohri, R. Valdez, D. M. Manthei, A. Gordon, L. Liu, D. D. Ho

This study evaluates antibody neutralization resistance of SARS-CoV-2 variants EG.5.1 and XBC.1.6 using pseudovirus assays and sera/mAbs, finding distinct evasion profiles and suggesting immunological imprinting and non-evasion-driven prevalence.

bioRxiv · Aug 21, 2023 · PreprintMicrobiology

Embryonic Vitamin D Deficiency Programs Hematopoietic Stem Cells to Induce Type 2 Diabetes

C. Bernal-Mizrachi, J. Oh, A. E. Riek, K. T. Bauerle, A. Dusso, K. McNerney, R. Barve, I. Darwech, J. Sprague, C. Moynihan, R. M. Zhang, T. Wang, X. Xing, D. Li, R. D. Head, , M. S. Sands

The paper shows that embryonic vitamin D deficiency in HSCs leads to diabetes in mice by altering epigenetic pathways and macrophage function.

bioRxiv · Sep 8, 2022Physiology

Computationally guided high-throughput design of self-assembling drug nanoparticles

D. Reker, Y. Rybakova, A. R. Kirtane, R. Cao, J. W. Yang, N. Navamajiti, A. Gardner, R. M. Zhang, T. Esfandiary, J. L'Heureux, T. von Erlach, E. M. Smekalova, D. Leboeuf, K. Hess, A. Lopes, , G. Traverso

This paper develops a high-throughput screening platform with machine learning to design self-assembling drug nanoparticles, identifying 101 novel formulations from 2.1 million combinations.

bioRxiv · Sep 30, 2019Bioengineering